News
Stocktwits on MSN56m
Pfizer’s Hemophilia Drug Meets Goals In Late-Stage Trial In Patients With Certain AntibodiesPfizer Inc. (PFE) on Thursday said that its therapy Hympavzi demonstrated improvement in bleeding outcomes for adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback